Immunoconjugate, methods for treating multiple myeloma in an individual, for dispensing immunoconjugate-mediated drug, for inhibiting, delaying and / or preventing tumor development and / or dispensing malignant tumor cells in a patient in need thereof, for treating an individual having a condition and to decrease the amount of cells in direct or indirect contact with immunoconjugates, a method for treating multiple myeloma in an individual, to dispense immunoconjugate-mediated medication, to inhibit, delay and / or prevent tumor cell development in a cell culture, to inhibit, delay and / or p
ELMAR KRAUS,CHRISTOPH BRUECHER,BENJAMIN DAELKEN,STEFFEN ZENG,FRANK OSTERROTH,CRISTOPH UHEREK,SILKE AIGNER,MATTHIAS GERMER
申请号：
BRPI0821449
公开号：
BRPI0821449A2
申请日:
2008.12.23
申请国别(地区):
BR
年份:
2015
代理人:
摘要：
Disclosed are immunoconjugates having in particular specificity for CD138 expressed on target cells and which display homogenous targeting. The immunoconjugates may be sterially hindered and/or contain a cleavable linker.
